Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$28.09 USD
+0.12 (0.43%)
Updated May 10, 2024 04:00 PM ET
After-Market: $28.15 +0.06 (0.21%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | 0.92 |
EPS Last Quarter | 0.98 |
Last EPS Surprise | 2.08% |
ABR | 1.21 |
Earnings ESP
|
1.64% |
---|---|
Current Year | 4.00 |
Next Year | 4.36 |
EPS (TTM) | 3.77 |
P/E (F1) | 7.02 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 647.07M | 661.50M | 2.68B | 2.93B |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 706.50M | 664.17M | 2.75B | 2.99B |
Low Estimate | 587.63M | 658.82M | 2.62B | 2.86B |
Year ago Sales | 545.00M | 637.00M | 3.05B | 2.68B |
Year over Year Growth Est. | 18.73% | 3.85% | -11.96% | 9.06% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.92 | 0.89 | 4.00 | 4.36 |
# of Estimates | 2 | 2 | 4 | 4 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.93 | 0.89 | 4.20 | 4.74 |
Low Estimate | 0.90 | 0.88 | 3.75 | 4.06 |
Year ago EPS | 0.85 | 0.79 | 4.49 | 4.00 |
Year over Year Growth Est. | 8.24% | 12.66% | -10.91% | 8.88% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.92 | 0.89 | 4.00 | 4.36 |
7 Days Ago | 0.90 | 0.89 | 3.95 | 4.32 |
30 Days Ago | 0.90 | 0.89 | 3.89 | 4.28 |
60 Days Ago | 0.90 | 0.89 | 3.90 | 4.28 |
90 Days Ago | NA | NA | 3.77 | 4.16 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.93 | 0.88 | 4.20 | 4.46 |
Zacks Consensus Estimate | 0.92 | 0.89 | 4.00 | 4.36 |
Earnings ESP | 1.64% | -0.57% | 5.00% | 2.41% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.98 | 1.15 | 0.79 | 0.85 | NA |
Estimate | 0.96 | 1.03 | 0.81 | 0.83 | NA |
Difference | 0.02 | 0.12 | -0.02 | 0.02 | 0.04 |
Surprise | 2.08% | 11.65% | -2.47% | 2.41% | 3.42% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more